Methods for using the obese product to stimulate hematopoietic development
Patent Number: 6838079
Date of First Priority Issue: Wednesday September 14th, 1994
Date Issued: Tuesday January 4th, 2005
Assignee: Indevus Pharmaceuticals, Inc. (Lexington, MA)
Inventors: Snodgrass, H. Ralph (Powell, OH); Cioffi, Joseph (New Albany, OH); Zupancic, Thomas Joel (Worthington, OH); Shafer, Alan Wayne (Lancaster, OH)
From Class: Expansion
Comments: No comments
Leptin is a natural inhibitor of fat. When you knock out leptin gene, mice are extremely obese. Interestingly, leptin has numerous other functions in the body, including stimulation of inflammatory responses, as well as immunologically predisposing to Th1.
In this patent the inventors identified that leptin stimulates hematopoiesis. This patent may be useful for treatment of post-chemotherapy myelosuppression.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.